Press release
Non-alcoholic Steatohepatitis Treatment Market Size, Share, Global Trends, Major Key Players and Geographical Forecast Till 2027
According to the report, increasing investment by numerous pharmaceutical companies in the research and development activities of effective molecules will contribute to the NASH treatment market growth during the forecast period. Furthermore, robust pipeline candidates and rising demand for effective drugs for NASH will also fuel market growth in the coming years.
Get Sample PDF:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/non-alcoholic-steatohepatitis-treatment-market-100656
Top Leaders Overview:
Some of the leading companies in the global Non-alcoholic Steatohepatitis Treatment Market are
GENFIT
Intercept Pharmaceuticals, Inc.,
Galmed Pharmaceuticals Ltd.,
Bristol-Myers Squibb Company
Sirius Therapeutics
Conatus Pharmaceuticals Inc
Galectin Therapeutics Inc
Immuron, Akcea Therapeutics among others
The report provides an elaborate analysis of the global non-alcoholic steatohepatitis treatment market. It also offers detailed insights regarding various aspects of the market, namely, growth drivers, challenges, upcoming trends, ongoing developments, key market players, and restraints. The competitive landscape of the global NASH treatment market, as well as the dominant regions, are presented in the report.
Ability to Reduce Weight to Fuel Glucagon-like Peptide-1 Receptor Drugs Segment
On the bases of drug class, the global NASH treatment market is divided into PPAR agonists, FXR-bile acid axis, anti-oxidants, GLP-1/DPP-4/SGLT-2 agent, anti-inflammatory agents, anti-fibrotic, and others. Out of these, the Glucagon-like peptide-1 receptor (GLP-1R) drugs are projected to acquire the largest global non-alcoholic steatohepatitis treatment market share during the forthcoming years. It would occur because these agonists drugs aid in decreasing weight, which further reduces fast accumulation in the liver and prevents a person from NASH.
Rising Incidence of Fatty Liver Disease in the U.S. to Boost Growth in North America
The global non-alcoholic steatohepatitis treatment market is geographically categorized into the Middle East and Africa, Europe, Latin America, North America, and Asia Pacific. Amongst these regions, North America is anticipated to lead the global NASH treatment market in the coming years. It would occur due to the increasing prevalence of fatty liver disease amongst the population in the U.S. The National Medical Advisory Committee (NAMC) estimated that at present, approximately 30 million people in the U.S. are diagnosed with NASH.
In Asia Pacific, on the other hand, the NASH treatment market is expected to grow at a rapid rate during the forecast period. Growing patient pool, rising demand for cost-effective treatment options, and overconsumption of unhealthy food are three of the most significant factors that will contribute to the market growth in this region.
Intercept Pharmaceuticals Submits New Drug Application to FDA for Obeticholic Acid
Intercept Pharmaceuticals, a biopharmaceutical company, based in the U.S., announced that it has submitted its New Drug Application (NDA) for obeticholic acid (OCA) to the FDA in September 2019. It is meant for the treatment of patients suffering from fibrosis because of NASH. OCA is the only therapy to meet the endpoint of a Phase 3 study in patients living with NASH. The company has asked for a Priority Review for the NDA. If approved, it would result in a six-month review period. The submission is based on the results from the Phase 3 Regenerate study in those affected by liver fibrosis due to NASH. Regenerate is a Phase 3, multicenter, randomized, placebo-controlled, and double-blind study that assesses the efficacy and safety of OCA on clinical outcomes in NASH affected patients.
Fortune Business Insights profiles some of the prominent organizations dominating the global non-alcoholic steatohepatitis (NASH) treatment market. They are given below:
Speak to Analyst:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/non-alcoholic-steatohepatitis-treatment-market-100656
Segmentation of the Non-alcoholic Steatohepatitis (NASH) Treatment Market
By Drug Class
PPAR agonists
FXR-bile acid axis
Anti-oxidants
GLP-1/DPP-4/SGLT-2 agent
Anti-inflammatory agents
Anti-fibrotic
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography
North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
Latin America (Brazil, Mexico, and Rest of Latin America)
Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)
https://www.businessresearchinsights.com/market-reports/giant-magnetoresistive-sensor-market-100006
https://www.businessresearchinsights.com/market-reports/magnetic-cartridges-market-100061
https://www.businessresearchinsights.com/market-reports/gallium-arsenide-gaas-wafer-market-100045
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
Linkedin | Twitter | BLogs
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-alcoholic Steatohepatitis Treatment Market Size, Share, Global Trends, Major Key Players and Geographical Forecast Till 2027 here
News-ID: 2562240 • Views: …
More Releases from Fortune Business Insights Pvt. Ltd.
Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 20 …
The global luxury goods market size was valued at USD 272.74 billion in 2022. The market is anticipated to grow from USD 284.00 billion in 2023 to USD 392.40 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period.
Luxury products signify the status symbol of an individual. Businesses focus on high-income populations with visually appealing designs and technology-integrated products. For instance, NFC-installed chips in jewelry; a product called…
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2 …
The global smart glass market size is anticipated to reach USD 15,788.0 million by 2027, owing to the rise in the use of smart glass for different applications such as aerospace, marine, architectural, and automotive.
Smart glass or switchable glass is glazing or a glass with altered transmission properties as and when heat, light, or voltage is applied. They are capable of changing their appearance from opaque to translucent to transparent…
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast …
According to Fortune Business Insights ™, the global non-alcoholic beverages market size is anticipated to rise significantly on account of the current trend of health and fitness and the rising inclination towards healthy beverages. The value of this market was USD 919.13 billion in 2019 and is expected to rise at a CAGR of 8.20% between 2020 to 2027 to reach USD 1,257.77 billion by the end of 2027.
List of…
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Dev …
Global Intravenous Iron Drugs Market Size research report 2022 offers an in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. The demand for refractive surgeries is anticipated to increase, attributed to the rise in the aging population and excessive use of digital devices, which has increased the screen time of the world population due to the…
More Releases for NASH
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
IQ4I Research published “Non-alcoholic steatohepataitis (NASH) Pipeline Analys …
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH. The report covers all the drugs that are in various phases of development (Discovery, Preclinical & Clinical). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, antibodies, stem cell therapies, recombinant proteins and RNA-based therapeutics, but excludes symptom relief drugs, generic combinations and supplemental drugs. The report…
Growing Prevalence of NASH to Increase Adoption of Therapeutics
"The Report OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has itemized the addition of a new market research report to its report repository. The research publication is titled, “Opportunity Analyzer: NASH - Opportunity Analysis and Forecasts to 2026.” The statistical surveying study is a watchful inspection of the general market…
OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026
First described in 1980, nonalcoholic steatohepatitis (NASH) (ICD-10-CM = K75.81) is a condition that develops as a subgroup of nonalcoholic fatty liver disease (NAFLD) when excessive fat buildup is accompanied by liver cell injury and inflammation. NAFLD is defined by excessive fat accumulation in the form of triglycerides (steatosis) in the liver. Progression of this condition to NASH dramatically increases the risk of cirrhosis, liver failure, and hepatocellular carcinoma, and…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
